JP2024521418A5 - - Google Patents
Info
- Publication number
- JP2024521418A5 JP2024521418A5 JP2023575836A JP2023575836A JP2024521418A5 JP 2024521418 A5 JP2024521418 A5 JP 2024521418A5 JP 2023575836 A JP2023575836 A JP 2023575836A JP 2023575836 A JP2023575836 A JP 2023575836A JP 2024521418 A5 JP2024521418 A5 JP 2024521418A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- inhibitor
- antigen
- cancer
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209736P | 2021-06-11 | 2021-06-11 | |
| US63/209,736 | 2021-06-11 | ||
| PCT/US2022/033058 WO2022261467A1 (en) | 2021-06-11 | 2022-06-10 | Radioimmunoconjugates and checkpoint inhibitor combination therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521418A JP2024521418A (ja) | 2024-05-31 |
| JP2024521418A5 true JP2024521418A5 (https=) | 2025-06-05 |
Family
ID=84426354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575836A Pending JP2024521418A (ja) | 2021-06-11 | 2022-06-10 | 放射性免疫複合体とチェックポイント阻害剤併用療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240285818A1 (https=) |
| EP (1) | EP4351662A1 (https=) |
| JP (1) | JP2024521418A (https=) |
| KR (1) | KR20240021227A (https=) |
| CN (1) | CN117794585A (https=) |
| AR (1) | AR126128A1 (https=) |
| AU (1) | AU2022291150A1 (https=) |
| BR (1) | BR112023026076A2 (https=) |
| CA (1) | CA3222948A1 (https=) |
| IL (1) | IL309243A (https=) |
| MX (1) | MX2023014778A (https=) |
| TW (1) | TW202317204A (https=) |
| WO (1) | WO2022261467A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4577527A1 (en) * | 2022-08-22 | 2025-07-02 | Abdera Therapeutics Inc. | Vhh antibody dota conjugates |
| KR20250171285A (ko) * | 2023-04-12 | 2025-12-08 | 코넬 유니버시티 | 암 치료용 방사선치료 접합체 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| US7922998B2 (en) * | 2003-01-13 | 2011-04-12 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
-
2022
- 2022-06-10 CA CA3222948A patent/CA3222948A1/en active Pending
- 2022-06-10 BR BR112023026076A patent/BR112023026076A2/pt unknown
- 2022-06-10 IL IL309243A patent/IL309243A/en unknown
- 2022-06-10 AR ARP220101547A patent/AR126128A1/es unknown
- 2022-06-10 US US18/568,234 patent/US20240285818A1/en active Pending
- 2022-06-10 KR KR1020247000772A patent/KR20240021227A/ko active Pending
- 2022-06-10 MX MX2023014778A patent/MX2023014778A/es unknown
- 2022-06-10 WO PCT/US2022/033058 patent/WO2022261467A1/en not_active Ceased
- 2022-06-10 TW TW111121757A patent/TW202317204A/zh unknown
- 2022-06-10 JP JP2023575836A patent/JP2024521418A/ja active Pending
- 2022-06-10 CN CN202280054208.4A patent/CN117794585A/zh active Pending
- 2022-06-10 EP EP22821133.0A patent/EP4351662A1/en active Pending
- 2022-06-10 AU AU2022291150A patent/AU2022291150A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022513700A5 (https=) | ||
| JP6368745B2 (ja) | プレターゲットキット、プレターゲット方法及びその使用試薬 | |
| JP2024521418A5 (https=) | ||
| JP6223962B2 (ja) | トランス−シクロオクテンジエノフィル及びジエンを有するイメージング又は治療用プレターゲティングキット | |
| JP5992435B2 (ja) | 循環からの生体分子の除去剤 | |
| EP3648801B1 (en) | Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy | |
| JP7194595B2 (ja) | グランザイムｂを指向するイメージングおよび治療 | |
| JP2020518674A5 (https=) | ||
| JP2020519643A (ja) | Ｍｓｌｎ標的三重特異性タンパク質及びその使用方法 | |
| JP2014500307A5 (https=) | ||
| JP2006526408A (ja) | 多価タンパク質複合体 | |
| RU2019139432A (ru) | Фармакокинетическая оптимизация бифункциональных хелатов и их применение | |
| JP2000510119A (ja) | ガンに対する標的コンビネーション免疫療法 | |
| TWI654179B (zh) | 放射性醫藥複合物 | |
| JP2022511471A5 (https=) | ||
| TW202128732A (zh) | 放射性金屬標定抗體、其製造方法、螯合連接子、及肽修飾抗體 | |
| JP7836270B2 (ja) | 抗ｄｏｔａ／抗腫瘍抗原二重特異性抗体による事前標的化放射免疫治療のためのｄｏｔａ－ハプテン組成物 | |
| JP2021502368A (ja) | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 | |
| EP3765523A1 (en) | Bispecific binding agents and uses thereof | |
| AU2022293573A1 (en) | Methods and materials for combining biologics with multiple chelators | |
| WO2023049963A1 (en) | Macrocycle containing compounds and radiolabelled complexes thereof, as ligands in targeted radiotherapy applications | |
| Kortylewicz et al. | Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2′-deoxyuridine, 5-iodo-3′-fluoro-2′, 3′-dideoxyuridine, and 3′-fluorothymidine for molecular radiotherapy of cancer: Synthesis and biological evaluation | |
| US12508329B2 (en) | Radiotherapeutic and companion imaging agents to target MC1R | |
| WO2017026502A1 (ja) | 抗ポドプラニン抗体及び抗体薬物複合体 | |
| KR20080099279A (ko) | 이관능성 레조르시놀, 티오레조르시놀, 및 디티오레조르시놀 유도체 금속 킬레이팅 컨쥬게이트 |